IDT Australia Limited engages in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and finished drug products worldwide. The company offers analytical method development, validation, and testing services for APIs, including cytotoxics, anti-cancer drugs, antibiotics, beta lactams, and controlled drugs, as well as generic medicines into finished dosage forms. Its services also include laboratory, functional support, project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs. The company is headquartered in Boronia, Australia.